Repeated Measurement of FIB-4 to Predict Long-Term Risk of HCC Development Up to 10 Years After SVR

PURPOSE: It is unclear whether and how the long-term risk of hepatocellular carcinoma (HCC) will change in hepatitis C virus (HCV) infected patients who have reached sustained virologic response (SVR) with direct-acting antivirals (DAA). In this study, we assessed the long-term risk of HCC up to 10...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Yanzheng, Yue, Ming, Jia, Linna, Wang, Yidi, Chen, Hongbo, Wang, Yifan, Zhang, Meiling, Feng, Yue, Yu, Rongbin, Yang, Sheng, Huang, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809166/
https://www.ncbi.nlm.nih.gov/pubmed/36606114
http://dx.doi.org/10.2147/JHC.S389874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809166/
https://www.ncbi.nlm.nih.gov/pubmed/36606114
http://dx.doi.org/10.2147/JHC.S389874

Ejemplares similares